Exhibit 10.1
AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT
This Agreement dated as of August 31, 1998 is among DYAX CORP.
(formerly known as Biotage, Inc.), a Delaware corporation (the "Company"),
and certain stockholders of the Company that are signatories hereto
(including for this purpose certain stockholders who have agreed in writing
to be bound by the terms of this Agreement).
R E C I T A L S
This Agreement amends and restates in its entirety the Amended and
Restated Registration Rights Agreement dated as of October 30, 1996 among the
Company and certain of such stockholders, as the same has been amended from
time to time prior to the date hereof (the "Prior Agreement").
Each Existing Stockholder (as defined below) owns (i) that number of
shares of Class A Series 1 Preferred Stock, par value $0.01 per share, of the
Company (the "SERIES 1 STOCK"), and/or Registrable Shares (as defined below)
of Common Stock, par value $0.01 per share (the "COMMON STOCK"), of the
Company set forth opposite the name of such Existing Stockholder on SCHEDULE
I and/or (ii) that number of shares of the Company's Common Stock, Class A
Series 2 Preferred Stock (the "SERIES 2 STOCK") and/or Class A Series 3
Preferred Stock (the "SERIES 3 STOCK") and/or Class A Series 4 Preferred
Stock (the "SERIES 4 STOCK") set forth opposite the name of such Existing
Stockholder on SCHEDULE II.
The Company is preparing to issue as of the date of this Agreement
shares of its Class A Series 5 Preferred Stock (the "SERIES 5 STOCK" and,
collectively with the Series 1 Stock, the Series 2 Stock, the Series 3 Stock
and the Series 4 Stock, the "PREFERRED STOCK") and to extend to the
purchasers of such Series 5 Stock (the "ADDITIONAL STOCKHOLDERS") certain of
the rights provided to the Existing Stockholders under the Prior Agreement.
The Preferred Stock is convertible into Common Stock pursuant to the terms of
the Company's Restated Certificate of Incorporation. The Additional
Stockholders and their holdings of Series 5 Stock purchased in the First
Closing (as that term is defined in the Convertible Preferred Stock Purchase
Agreement (the "Purchase Agreement") of even date herewith between the
Company and the Additional Stockholders) are listed on SCHEDULE III. Schedule
III of the Agreement may be revised from time to time to include more
Additional Stockholders following Subsequent Closings under the Purchase
Agreement.
The Company and the Stockholders (as defined below) deem it to be in
their respective best interests to set forth the rights of the Stockholders
in connection with public offerings and sales of the Common Stock.
NOW, THEREFORE, in consideration of the premises and mutual
covenants and obligations hereinafter set forth, the Company and the
Stockholders hereby agree as follows:
SECTION 1. CERTAIN DEFINITIONS.
As used in this Agreement, the following terms have the following
respective meanings:
1
"COMMISSION" means the Securities and Exchange Commission, or any
other Federal agency at the time administering the Securities Act and/or the
Exchange Act.
"EXCHANGE ACT" means the Securities Exchange Act of 1934 or any
similar Federal statute, and the rules and regulations of the Commission
issued under such Act, as they each may, from time to time, be in effect.
"EXISTING STOCKHOLDERS" means, individually and collectively, the
holders of Registrable Shares who were parties to the Prior Agreement.
"INITIAL PUBLIC OFFERING" shall mean the closing of the first fully
underwritten, firm commitment public offering pursuant to an effective
Registration Statement covering the offer and sale by the Company of its
Common Stock, resulting in aggregate net proceeds to the Company (after
deducting underwriting discounts and commissions) of at least $20,000,000 and
at a per share price of at least (i) $10.00 per share if the offering is
closed prior to December 31, 2000 and (ii) $15.00 if the offering is closed
thereafter (each such amount to be equitably adjusted upon the occurrence of
any stock split, stock dividend, combination, reclassification or other
similar event).
"REGISTRABLE SHARES" means (i) the shares of Common Stock issued or
issuable upon the conversion of the Preferred Stock, (ii) the shares of
Common Stock listed on SCHEDULE I attached hereto issued upon conversion of
the former Class A Preferred Stock and the former Class B Preferred Stock of
the Company and (iii) any other shares of Common Stock of the Company issued
or issuable in respect of such shares of Common Stock or in respect of shares
of the Preferred Stock (because of stock splits, stock dividends,
reclassifications, recapitalizations or similar events). Wherever reference
is made in this Agreement to a request or consent of holders of a certain
percentage of Registrable Shares, or to a number or percentage of Registrable
Shares held by a Stockholder, such reference shall be deemed to mean
Registrable Shares on a Common Stock equivalent basis and to include all
shares of Preferred Stock convertible into Registrable Shares.
"REGISTRATION EXPENSES" has the meaning ascribed thereto in Section
5.
"REGISTRATION STATEMENT" means a registration statement filed by the
Company with the Commission for a public offering and sale of securities of
the Company (other than a registration statement on Form S-8 or Form S-4, or
their successors, or any other form for a limited purpose, or any
registration statement covering only securities proposed to be issued in
exchange for securities or assets of another corporation).
"SECURITIES ACT" means the Securities Act of 1933 or any similar
Federal statute, and the rules and regulations of the Commission issued under
such Act, as they each may, from time to time, be in effect.
"STOCKHOLDERS" means, individually and collectively, the Existing
Stockholders, the Additional Stockholders, and any other stockholders (or any
of them) of the Company that are signatories hereto, and any persons or
entities to whom the rights granted under this Agreement are transferred by
such stockholders (or any of them), and their successors or assigns to the
extent permitted by Section 14 hereof.
2
SECTION 2. REQUIRED REGISTRATIONS.
(a) Commencing on the first anniversary of the closing of the
Initial Public Offering of the Company, a Stockholder or Stockholders holding
in the aggregate at least 50% of the Registrable Shares or stockholders
holding in the aggregate at least 50% of the Series 5 Stock or the Common
Stock into which the Series 5 Stock is convertible, may request, in writing,
that the Company effect the registration on Form S-1 or Form SB-2 (or any
successor forms) Registrable Shares having an anticipated net aggregate
offering price in excess of $5,000,000 (after deducting underwriting
discounts and commissions). Any demand registration pursuant to this Section
2 must be underwritten on a firm commitment basis and the right of other
Stockholders to participate shall be conditioned on such Stockholders'
participation in such underwriting upon the same terms and conditions. Upon
receipt of any such request, the Company shall promptly give written notice
of such proposed registration to all Stockholders. Such Stockholders shall
have the right, by giving written notice to the Company within 30 days after
the Company provides its notice, to elect to have included in such
registration such of their Registrable Shares as such Stockholders may
request in such notice of election, subject to the approval of the
underwriter managing the offering. Thereupon, the Company shall, as
expeditiously as possible, use its best efforts to effect the registrations,
on Form S-1 or Form SB-2 (or any successor form), of all Registrable Shares
which the Company has been requested to so register.
(b) At any time after the Company becomes eligible to file a
Registration Statement on Form S-3 (or any successor form relating to
secondary offerings), a Stockholder or Stockholders holding in the aggregate
Registrable Shares having a market value of $1,000,000, may request the
Company, in writing, to effect the registration on Form S-3 (or any successor
form), of all or such portion of the Registrable Shares as such holder or
holders shall specify. Upon receipt of any such request, the Company shall
promptly give written notice of such proposed registration to all
Stockholders. Such Stockholders shall have the right, by giving written
notice to the Company within 30 days after the Company provides its notice,
to elect to have included in such registration such of their Registrable
Shares as such Stockholders may request in such notice of election.
Thereupon, the Company shall, as expeditiously as possible, use its best
efforts to effect the registration on Form S-3 (or any successor form) of all
Registrable Shares which the Company has been so requested to register.
(c) The Company shall not be required to effect more than two
registrations pursuant to paragraph (a) above provided however the Additional
Stockholders shall be entitled to demand the filing of a registration
statement pursuant to paragraph (a) above on not less than two occasions
whether or not they have included any of their Registrable Shares in prior
Registration Statements filed as a result of the demand by other Stockholders
pursuant to paragraph (a) above. Unless otherwise requested by the selling
Stockholders, a registration pursuant to paragraph (a) above shall not count
as one of the permitted registrations until it has become effective. Unless
otherwise requested by the selling Stockholders, the last registration
pursuant to paragraph (a) above shall not count as one of the permitted
registrations unless the holders of Registrable Shares are able to register
and sell at least ninety percent (90%) of the Registrable Shares requested to
be included in such registration. In addition, the Company shall not be
required to effect any registration (other than on Form S-3 or any successor
form relating to secondary offerings) within six months after the effective
date of any other Registration Statement of the
3
Company. Under paragraph (b) above, the Stockholder or Stockholders holding
in the aggregate Registrable Shares having a market value of $1,000,000 shall
have the right to require the Company to effect an unlimited number of
registrations on Form S-3, however, in any one year the Company shall not be
required to effect more than one such registration on Form S-3, and any such
registration on Form S-3 shall be separated from any previous registration by
a period of at least six months.
(d) If at the time of any request to register Registrable Shares
pursuant to this Section 2, the Company is engaged or has firm plans to
engage within 90 days of the time of the request in a registered public
offering as to which the Stockholders may include Registrable Shares pursuant
to Section 3 or is engaged in any other activity which, in the good faith
determination of the Company's Board of Directors, would be adversely
affected by the requested registration to the material detriment of the
Company, then the Company may at its option direct that such request be
delayed for a period not in excess of one hundred twenty (120) days from the
effective date of such offering or the date of commencement of such other
material activity, as the case may be, such right to delay a request to be
exercised by the Company not more than once.
SECTION 3. INCIDENTAL REGISTRATION.
(a) Whenever the Company proposes to file a Registration Statement
(other than pursuant to Section 2), it will, prior to such filing, give
written notice to all Stockholders of its intention to do so and, upon the
written request of a Stockholder or Stockholders given within 20 days after
the Company provides such notice (which request shall state the intended
method of disposition of such Registrable Shares), the Company shall use its
best efforts to cause all Registrable Shares which the Company has been
requested to register to be registered under the Securities Act to the extent
necessary to permit their sale or other disposition in accordance with the
intended methods of distribution specified in the request of such
Stockholder(s); provided that the Company shall have the right to postpone or
withdraw any registration effected pursuant to this Section 3 without
obligation to any Stockholder.
(b) In connection with any offering under this Section 3 involving
an underwriting, the Company shall not be required to include any Registrable
Shares in such underwriting unless the holders thereof accept the terms of
the underwriting as agreed upon between the Company and the underwriters
selected by it, and then only in such quantity as will not, in the opinion of
the underwriters, jeopardize the success of the offering by the Company. If
in the Opinion of the managing underwriter the registration of all, or part
of, the Registrable Shares which the holders have requested to be included
would materially and adversely affect such public offering, then the Company
shall be required to include in the underwriting only that number of
Registrable Shares, if any, which the managing underwriter believes may be
sold without causing such adverse effect. In the event of such a reduction in
the number of shares to be included in the underwriting, all shares other
than Registrable Shares shall be excluded from the underwriting before any
Registrable Shares are excluded from the underwriting and the holders of
Registrable Shares who have requested registration shall participate in the
underwriting pro rata based upon their total ownership of Registrable Shares
(or in any other proportion as agreed upon by such holders) and if any holder
would thus be entitled to include more shares than such holder requested to
be registered, the excess shall be allocated among other requesting holders
pro rata based on their ownership of Registrable Shares.
4
SECTION 4. REGISTRATION PROCEDURES. If and whenever the Company is
required by the provisions of this Agreement to use its best efforts to
effect the registration of any of the Registrable Shares under the Securities
Act, the Company shall:
(a) provide to the selling Stockholders drafts of the Registration
Statement and an opportunity to comment thereon and participate in the
preparation thereof prior to filing the Registration Statement with the
Commission;
(b) file with the Commission the Registration Statement and use its
best efforts to cause the Registration Statement to become and remain
effective;
(c) as expeditiously as possible prepare and file with the
Commission any amendments and supplements to the Registration Statement and
the prospectus included in the Registration Statement as may be necessary to
keep the Registration Statement effective for a period of not less than 120
days from the effective date;
(d) as expeditiously as possible furnish to each selling Stockholder
such reasonable numbers of copies of the prospectus, including a preliminary
prospectus, in conformity with the requirements of the Securities Act, and
such other documents as the selling Stockholders may reasonably request in
order to facilitate the public sale or other disposition of the Registrable
Shares owned by the selling Stockholders; and
(e) as expeditiously as possible use its best efforts to register or
qualify the Registrable Shares covered by the Registration Statement under
the securities or blue sky laws of such states as the selling Stockholders
shall reasonably request, and do any and all other acts and things that may
be necessary or desirable to enable the selling Stockholders to consummate
the public sale or other disposition in such jurisdictions of the Registrable
Shares owned by the selling Stockholders; PROVIDED, HOWEVER, that the Company
shall not be required in connection with this paragraph (e) to qualify as a
foreign corporation or execute a general consent to service of process in any
jurisdiction.
(f) obtain for the selling Stockholders such opinions of counsel to
the Company or comfort letters from the Company's accountants, addressed to
the selling Stockholders, as may be deemed reasonably requested by the
selling Stockholders holding a majority of the Registrable Shares included in
the Registration Statement.
If the Company has delivered preliminary or final prospectuses to
the selling Stockholders and after having done so the prospectus is amended
to comply with the requirements of the Securities Act, the Company shall
promptly notify the Selling Stockholders and, if requested, the selling
Stockholders shall immediately cease making offers of Registrable Shares and
shall return all prospectuses to the Company. The Company shall promptly
provide the selling Stockholders with revised prospectuses and, following
receipt of the revised prospectuses, the selling Stockholders shall be free
to resume making offers of the Registrable Shares.
SECTION 5. ALLOCATION OF EXPENSES. The Company shall pay the
Registration Expenses for the registrations requested by the Stockholders
pursuant to Section 2 of this Agreement and of all registrations pursuant to
Section 3 of this Agreement. If a registration
5
requested by the Stockholders pursuant to paragraph (a) of Section 2 is
withdrawn at the request of the Stockholders requesting it (other than as a
result of information concerning the business or financial condition of the
Company which is made known to the Stockholders after the date on which such
registration was requested) and if the requesting Stockholders elect not to
have such registration counted as a registration requested under paragraph
(a) of Section 2, the requesting Stockholders shall pay the Registration
Expenses of such registration pro rata in accordance with the number of their
Registrable Shares previously proposed to be included in such registration.
For purposes of this Agreement, the term "Registration Expenses" shall mean
all expenses incurred by the Company in complying with this Agreement,
including, without limitation, all registration and filing fees, exchange
listing fees, printing expenses, fees and disbursements of counsel for the
Company and one counsel for the selling Stockholders, state blue sky fees and
expenses, and the expense of any special audits incident to or required by
any such registration, but excluding underwriting discounts and selling
commissions. Such underwriting discounts and selling commissions shall be
borne pro rata by the selling Stockholders in accordance with the number of
their Registrable Shares included in such registration.
SECTION 6. INDEMNIFICATION. In the event of any registration of any
of the Registrable Shares under the Securities Act pursuant to this
Agreement, the Company will indemnify and hold harmless the seller of such
Registrable Shares, each underwriter of such Registrable Shares and each
other person if any, who controls such seller or underwriter within the
meaning of the Securities Act or the Exchange Act against any losses, claims,
damages or liabilities, joint or several, to which such seller, underwriter
or controlling person may become subject under the Securities Act, the
Exchange Act, state securities laws or otherwise, insofar as such losses,
claims, damages or liabilities (or actions in respect thereof) arise out of
or are based upon any untrue statement or alleged untrue statement of any
material fact contained in any Registration Statement under which such
Registrable Shares were registered under the Securities Act, any preliminary
prospectus or final prospectus contained in such Registration Statement, or
any amendment or supplement to such Registration Statement, or arise out of
or are based upon the omission or alleged omission to state a material fact
required to be stated therein or necessary to make the statements therein not
misleading, and the Company will reimburse such seller, underwriter or
controlling person for any legal or any other expenses reasonably incurred by
such seller, underwriter or controlling person, respectively, in connection
with investigating or defending any such loss, claim, damage, liability or
action; PROVIDED, HOWEVER, that the Company will not be liable in any such
case to the extent that any such loss, claim, damage or liability arises out
of or is based upon any untrue statement or omission made in such
Registration Statement, preliminary prospectus or prospectus, or any such
amendment or supplement, in reliance upon and in conformity with information
furnished to the Company, in writing, by or on behalf of such seller,
underwriter or controlling person specifically for use in the preparation
thereof.
In the event of any registration of any of the Registrable Shares
under the Securities Act pursuant to this Agreement, each seller of
Registrable Shares included in such registration, severally and not jointly,
will indemnify and hold harmless the Company, each of its directors and
officers and each underwriter (if any) and each person, if any, who controls
the Company or any such underwriter within the meaning of the Securities Act
or the Exchange Act, against any losses, claims, damages or liabilities,
joint or several, to which the Company, such directors and officers,
underwriter or controlling persons may become under the Securities Act,
Exchange Act,
6
state securities laws or otherwise, insofar as such losses, claims, damages
or liabilities (or actions in respect thereof) arise out of or are based upon
any untrue statement or alleged untrue statement of a material fact contained
in any Registration Statement under which such Registrable Shares were
registered under the Securities Act, any preliminary prospectus or final
prospectus contained in the Registration Statement, or any amendment or
supplement to the Registration Statement, or arise out of or are based upon
any omission or alleged omission to state a material fact required to be
stated therein or necessary to make the statements therein not misleading, if
the statement or omission was made in reliance upon and in conformity with
information furnished in writing to the Company by or on behalf of such
seller, specifically for use in connection with the preparation of such
Registration Statement, prospectus, amendment or supplement; PROVIDED,
HOWEVER, that the obligations of such seller hereunder shall be limited to an
amount equal to the proceeds to such seller from Registrable Shares sold in
such registration. Indemnification of any underwriter pursuant to this
Section 6 shall not be interpreted as providing relief of such underwriter
from any or all of its due diligence obligations. Further, an underwriter
shall not be entitled to indemnification pursuant to this subsection in the
event that it fails to deliver to any selling Stockholder any preliminary or
final or revised prospectus, as required by the Rules and Regulations of the
Commission. Finally, in the event that any error in a preliminary prospectus
of the Company is subsequently corrected in the final prospectus of the
Company for a particular offering, no indemnification shall be provided
pursuant to this Section unless the Company has provided the seller of
Registrable Shares against whom indemnification is sought with sufficient
copies of the final prospectus and any amendments and supplements thereto in
accordance with the Company's obligations under Section 4 of this Agreement.
Each party entitled to indemnification under this Section 6 (the
"Indemnified Party ) shall give notice to the party required to provide
indemnification (the "Indemnifying Party") promptly after such Indemnified
Party has actual knowledge of any claim as to which indemnity may be sought,
and shall permit the Indemnifying Party to assume the defense of any such
claim or any litigation resulting therefrom; PROVIDED, that counsel for the
Indemnifying Party, who shall conduct the defense of such claim or
litigation, shall be approved by the Indemnified Party (whose approval shall
not be unreasonably withheld); and, PROVIDED, FURTHER, that the failure of
any Indemnified Party to give notice as provided herein shall not relieve the
Indemnifying Party of its obligations under this Agreement. The Indemnified
Party may participate in such defense at such party's expense; PROVIDED,
HOWEVER, that the Indemnifying Party shall pay such expense if representation
of such Indemnified Party by the counsel retained by the Indemnifying Party
would be inappropriate due to actual or potential differing interests between
the Indemnified Party and any other party represented by such counsel in such
proceeding. No Indemnifying Party, in the defense of any such claim or
litigation shall, except with the consent of each Indemnified Party, consent
to entry of any judgment or enter into any settlement which does not include
as an unconditional term thereof the giving by the claimant or plaintiff to
such Indemnified Party of a release from all liability in respect of such
claim or litigation, and no Indemnified Party shall consent to entry of any
judgment or settle such claim or litigation without the prior written consent
of the Indemnifying Party.
Except to the extent otherwise provided above, if the
indemnification provided for in this Section 6 is for any reason unavailable
or insufficient to hold harmless an indemnified party then each such
indemnifying party in lieu of indemnifying such indemnified party, shall
contribute to the amount paid or payable by such indemnified party as a
result of the losses, claims, damages,
7
judgments or liabilities referred to above (i) in such proportion as is
appropriate to reflect the relative benefits received by the Company, the
holders of Registrable Shares and the underwriters from the offering of the
shares or (ii) if the allocation provided by clause (i) above is not
permitted by applicable law, in such proportion as is appropriate to reflect
not only the relative benefits referred to in clause (i) above but also the
relative fault of the Company, the holders of Registrable Shares and the
underwriters in connection with the statement or omission which resulted in
such losses, claims, damages, judgments or liabilities, as well as any other
relevant equitable considerations. The relative benefits received by the
Company, the holders of Registrable Shares and the underwriters shall be
deemed to be in the same proportion as the total net proceeds from the
offering of the shares (before deducting expenses) received by the Company
and the holders of Registrable Shares and the total underwriting discounts
and commissions received by the underwriters bear to each other. The relative
fault of the Company, the holders of Registrable Shares and the underwriters
shall be determined by reference to, among other things, whether the untrue
or alleged untrue statement of a material fact or the omission or alleged
omission to state a material fact relates to information supplied by the
Company, the holder of Registrable Shares or the underwriters and that
party's relative intent, knowledge, access to information and opportunity to
correct or prevent such untrue statements or omissions.
SECTION 7. INDEMNIFICATION WITH RESPECT TO UNDERWRITTEN OFFERING. In
the event that Registrable Shares are sold pursuant to a Registration
Statement in an underwritten offering pursuant to Section 2, the Company
agrees to enter into an underwriting agreement containing customary
representations and warranties with respect to the business and operations of
an issuer of the securities being registered and customary covenants and
agreements to be performed by such issuer, including without limitation
customary provisions with respect to indemnification by the Company of the
underwriters of such offering.
SECTION 8. INFORMATION BY HOLDER. Each holder of Registrable Shares
included in any registration shall furnish to the Company such information
regarding such holder and the distribution proposed by such holder as the
Company may request in writing and as shall be required in connection with
any registration, qualification or compliance referred to in this Agreement.
SECTION 9. "STAND-OFF" AGREEMENT. Stockholders, if requested by the
Company and an underwriter of Common Stock or other securities of the
Company, shall agree not to sell or otherwise transfer or dispose of any
Registrable Shares of the Company held by such Stockholder for a specified
period of time (not to exceed 180 days) following the effective date of a
Registration Statement; PROVIDED THAT, all Stockholders holding more than
five percent of the outstanding Common Stock and all officers and directors
of the Company enter into similar agreements. Such agreement shall be in
writing in a form satisfactory to the Company and such underwriter. The
Company may impose stop-transfer instructions with respect to the Registrable
Shares or other securities subject to the foregoing restriction until the end
of the stand-off period.
SECTION 10. RULE 144 REQUIREMENTS. With a view to making available
to the Stockholders the benefits of Rule 144 promulgated under the Securities
Act and any other rule or regulation of the Commission that may at any time
permit a Stockholder to sell securities of the Company to the public without
registration, the Company agrees to use its best efforts to:
8
(a) make and keep public information available, as those terms are
understood and defined in Rule 144 under the Securities Act;
(b) use its best efforts to file with the Commission in a timely
manner all reports and other documents required of the Company under the
Securities Act and the Exchange Act (at any time after it has become subject
to such reporting requirements); and
(c) furnish to any holder of Registrable Shares upon request a
written statement by the Company as to its compliance with the reporting
requirements of said Rule 144 (at any time after 90 days after the closing of
the first sale of securities by the Company pursuant to a Registration
Statement), and of the Securities Act and the Exchange Act (at any time after
it has become subject to such reporting requirements), a copy of the most
recent annual or quarterly report of the Company, and such other reports and
documents of the Company as such holder may reasonably request to avail
itself of said Rule 144 or any similar rule or regulation of the Commission
allowing it to sell any such securities without registration.
SECTION 11. SELECTION OF UNDERWRITER. In the case of any
registration effected pursuant to Section 2, the requesting Stockholders
shall have the right to designate the managing underwriter, subject to the
approval of the Company, which approval may not be unreasonably withheld or
delayed.
SECTION 12. NO CONFLICT OF RIGHTS. The Company shall not, after the
date hereof, grant any registration rights which would adversely affect or
impair the registration rights granted hereby.
SECTION 13. SUCCESSORS AND ASSIGNS. Except as provided in Section 14
hereof, the provisions of this Agreement shall be binding upon and inure to
the benefit of, the respective successors, assigns, heirs, executors and
administrators of the parties hereto.
SECTION 14. ASSIGNMENT. (a) The rights granted to the Stockholders
under this Agreement may not be transferred except to (i) a member of such
Stockholder's immediate family or a trust for the exclusive benefit of one or
more persons who are members of such Stockholder's immediate family, either
during the lifetime of such Stockholder or in death by will or intestacy or
(ii) any transferee or successor who is (x) a general or limited partner,
officer or other affiliate of such Stockholder or any other affiliate of the
Company (regardless of whether such transferee is a direct or indirect
competitor of the Company) or (y) who acquires at least 80,000 Registrable
Shares (equitably adjusted to reflect stock splits, dividends, combinations
and like adjustments) (or such lesser number of shares as may constitute such
Stockholder's entire holding of Registrable Shares) and who is not directly
or indirectly a competitor of the Company or a partner, officer, director,
employee or owner of more than 1% of the outstanding securities of any
publicly traded direct or indirect competitor of the Company; PROVIDED,
HOWEVER, that the Company is given written notice by the transferee stating
the name and address of the transferee and identifying the securities with
respect to which such rights are being assigned. Notwithstanding the
foregoing restrictions with respect to competitors, a professional
institutional investor owning up to 20% of the outstanding securities of a
direct or indirect competitor of the Company may be a transferee of such
rights provided that it complies with the provisions of the previous
sentence. For purposes hereof the term "affiliate" shall mean,
9
with respect to the Company, any officer, director or holder of 5% or more of
any class of the Company's stock and, with respect to any Stockholder, any
person who or which controls, is controlled by or under common control with
such Stockholder.
(b) TRANSFEREES. Any transferee to whom rights under this Agreement
are transferred shall, as a condition to such transfer, deliver to the
Company a written instrument by which such transferee agrees to be bound by
the obligations imposed upon the Stockholders hereby to the same extent as if
such transferee were a Stockholder hereunder.
(c) SUBSEQUENT TRANSFEREES. A transferee to whom rights are
transferred pursuant to this Section 14 may not again transfer such rights to
any other person or entity, other than as provided in (a) and (b) above.
SECTION 15. TERMINATION OF REGISTRATION RIGHTS. Notwithstanding any
other provision of this Agreement, the Company shall not be required pursuant
to this Agreement (i) to give notice of any proposed registration pursuant to
Section 2 or Section 3 to any Stockholder if, based on record holdings, such
Stockholder could then sell pursuant to Rule 144 (or any similar rule) under
the Securities Act in a single 90-day period all Registrable Shares
registered in the name of such holder, or (ii) to include in any offering any
Registrable Shares of a Stockholder holding fewer than 100,000 Registrable
Shares if such Stockholder could then sell pursuant to Rule 144 (or any
similar rule) under the Securities Act in a single 90-day period all of such
Registrable Shares requested to be registered in such offering, provided,
however, that any Additional Stockholder that is a limited partnership or
limited liability company shall be entitled to include any of its Registrable
Shares in a proposed registration to the extent that such Additional
Stockholder requires such registration for distribution to its limited
partner or member.
SECTION 16. NOTICES. All notices, requests, consents, and other
communications under this Agreement shall be in writing and shall be
delivered by hand, telecopy or telegram, overnight courier or first class
certified or registered mail, return receipt requested, postage prepaid:
If to the Company, to Dyax Corp., One Kendall Square, Building 600
- -5th Floor, Cambridge, MA 02139, Attn: President, or such other address or
addresses as may have been furnished in writing by the Company to the
Stockholders, with a copy to Nathaniel S. Gardiner, Esq., Palmer & Dodge LLP,
One Beacon Street, Boston, Massachusetts 02108;
If to any Stockholder, to its address set forth on SCHEDULE I,
SCHEDULE II or SCHEDULE III (with a copy to additional parties so listed for
any such Stockholder), as the case may be, or such other address or addresses
as may have been furnished to the Company in writing by such Stockholder.
Notices provided in accordance with this Section 16 shall be deemed
delivered on the date of personal delivery, telecopy or telegram, the next
business day after delivery by overnight courier, or 48 hours after the date
of mailing.
10
SECTION 17. ENTIRE AGREEMENT. This Agreement embodies the entire
agreement and understanding between the parties hereto with respect to the
subject matter hereof and supersedes all prior agreements and understandings
relating to such subject matter, including without limitation the Prior
Agreement.
SECTION 18. AMENDMENTS AND WAIVERS. This Agreement may be amended
and the observance of any term of this Agreement may be waived (either
generally or in a particular instance and either retroactively or
prospectively), with the written consent of the Company and the holders of a
majority of the Registrable Shares; provided, however, that no amendment may
be made that would adversely affect the distinct rights of the Additional
Stockholders under Section 2 hereof without the express consent of the
Additional Stockholders holding at least 50.1% of the Series 5 Stock. Any
amendment or waiver effected in accordance with this Section 18 shall be
binding upon each holder of Registrable Shares and the Company. No waivers of
or exceptions to any term, condition or provision of this Agreement, in any
one or more instances, shall be deemed to be, or construed as, a further or
continuing waiver of any such term, condition or provision.
SECTION 19. COUNTERPARTS. This Agreement may be executed in several
counterparts, each of which shall be deemed an original, but all of which
together shall constitute one and the same instrument. Execution of an
undertaking agreeing to be bound by the terms of this Agreement shall be
deemed to be a counterpart signature to this Agreement.
SECTION 20. HEADINGS. The headings of the sections, subsections and
paragraphs of this Agreement have been added for convenience only and shall
not be deemed to be a part of this Agreement.
SECTION 21. SEVERABILITY. The invalidity or unenforceability of any
provision of this Agreement shall not affect the validity or enforceability
of any other provision.
SECTION 22. GOVERNING LAW. This Agreement shall be governed by and
construed in accordance with the laws of the State of Delaware.
[Remainder of Page Intentionally left blank]
[Signature Pages to follow]
11
IN WITNESS WHEREOF, the undersigned have hereunto set their hand as
of the day and year first above written.
COMPANY:
DYAX CORP.
By: /s/ HENRY E. BLAIR
--------------------------------
Henry E. Blair
President
12
STOCKHOLDERS:
OAK INVESTMENT PARTNERS IV
By Oak Associates IV, Limited Partnership, as
General Partner
By: /s/ EILEEN M. MORE
--------------------------------
Eileen M. More
General Partner
OAK IV AFFILIATES FUND
By Oak IV Affiliates, as General Partner
By: /s/ EILEEN M. MORE
--------------------------------
Eileen M. More
General Partner
GATEWAY VENTURE PARTNERS
III, L.P.
By Gateway Associates, L.P.,
as General Partner
By: /s/ CONSTANTINE ANAGNOSTOPOULOS
--------------------------------
Constantine Anagnostopoulos
H&Q HEALTHCARE INVESTORS
By: /s/ ALAN G. CARR
--------------------------------
Alan G. Carr
President
13
H&Q LIFE SCIENCES INVESTORS
By: /s/ ALAN G. CARR
--------------------------------
Alan G. Carr
President
LOEB INVESTORS CO. 106C
By Pinpoint Partners Corporation,
as General Partner
By: /s/ THOMAS KEMPNER
--------------------------------
Thomas Kempner
President
LOEB INVESTORS CO. 106
By Pinpoint Partners Corporation,
as General Partner
By: /s/ THOMAS KEMPNER
--------------------------------
Thomas Kempner
President
LOEB INVESTORS CO. 106A
By Pinpoint Partners Corporation,
as General Partner
By: /s/ THOMAS KEMPNER
--------------------------------
Thomas Kempner
President
14
LOEB INVESTORS CO. 106B
By Pinpoint Partners Corporation,
as General Partner
By: /s/ THOMAS KEMPNER
--------------------------------
Thomas Kempner
President
/s/ RICHARD SILVERMAN
-----------------------------------
Richard Silverman
PRINCE VENTURE PARTNERS IV
LIMITED PARTNERSHIP
By Prince Ventures Limited Partnership,
as General Partner
By: /s/ JAMES FORDYCE
--------------------------------
James Fordyce
General Partner
/s/ CHARLES I. TYLER
-----------------------------------
Charles I. Tyler
/s/ MARGARET B. TYLER
-----------------------------------
Margaret B. Tyler
-----------------------------------
George J. Hill
/s/ JOSEPH BUTERA
-----------------------------------
Joseph Butera
15
/s/ HENRY R. LEWIS
-----------------------------------
Henry R. Lewis
/s/ SIDNEY R. KNAFEL
-----------------------------------
Sidney R. Knafel
/s/ HENRY E. BLAIR
-----------------------------------
Henry E. Blair
ZINSMEYER TRUSTS PARTNERSHIP
By: /s/ ANDREW R. ZINSMEYER
--------------------------------
Andrew R. Zinsmeyer
Managing Partner
BANCBOSTON VENTURES, INC.
By: /s/ MARCIA T. BATES
--------------------------------
Marcia T. Bates
Managing Director
GMMI SBIC, INC.
By GMM Investors Corp.,
as General Partner
By: /s/ JAMES GOODMAN
--------------------------------
James Goodman
President
16
BERWICK PARTNERS II
By: /s/ ANTHONY BIANCANELLO
--------------------------------
Anthony Biancanello
General Partner
NEW YORK LIFE INSURANCE
COMPANY
By: /s/ RICHARD F. DRAKE
--------------------------------
Richard F. Drake
Director, Venture Capital
/s/ PETER FEINSTEIN
-----------------------------------
Peter Feinstein
HEALTHCARE VENTURES V, L.P.
By HealthCare Partners V, L.P.,
as General Partner
By: /s/ JEFFREY STEINBERG
--------------------------------
Jeffrey Steinberg,
Administrative Partner
17
/s/ ROBERT ANDERSON
-----------------------------------
Robert Anderson
-----------------------------------
Mike Grossman
/s/ FRANK HANO
-----------------------------------
Frank Hano
/s/ JOHN NESTLE
-----------------------------------
John Nestle
/s/ JACK ANDEREGG
-----------------------------------
Jack Anderegg
-----------------------------------
William Nichols
18
RHO MANAGEMENT TRUST II
By Rho Management Company, Inc.
as Investment Advisor
By: /s/ JOSHUA RUCH
--------------------------------
Joshua Ruch
HUDSON TRUST
c/o Summit Asset Management
By: /s/ SCOTT M. CICCONE
--------------------------------
Scott M. Ciccone
Attorney-in-fact
ALTA BIOPHARMA PARTNERS, L.P.
By Alta BioPharma Management, LLC
By: /s/ DANIEL JANNEY
--------------------------------
Daniel Janney
Member
ALTA EMBARCADERO BIOPHARMA, LLC
By Alta Embarcadero BioPharma, LLC
By: /s/ GARRETT GRUENER
--------------------------------
Garrett Gruener
Member
/s/ HENRY E. BLAIR
-----------------------------------
Henry E. Blair
/s/ JOSEPH L. BUTERA
-----------------------------------
Joseph L. Butera
19
/s/ AUSTIN R. CAMPBELL
-----------------------------------
/s/ MYRA B. CAMPBELL
-----------------------------------
Austin R. Campbell and Myra B. Campbell
as Co-Owners
CGC INVESTORS, L.P.
By: /s/ A. BARR DOLAN
--------------------------------
A. Barr Dolan
General Partner
CGC INVESTORS, L.P.
By: /s/ STEVEN P. BIRD
--------------------------------
Steven P. Bird
General Partner
CHARTER GROWTH CAPITAL, L.P.
By: /s/ A. BARR DOLAN
--------------------------------
A. Barr Dolan
General Partner
20
CHARTER GROWTH CAPITAL, L.P.
By: /s/ STEVEN P. BIRD
--------------------------------
Steven P. Bird
General Partner
CHARTER GROWTH CAPITAL
CO-INVESTMENT FUND, L.P.
By: /s/ A. BARR DOLAN
--------------------------------
A. Barr Dolan
General Partner
CHARTER GROWTH CAPITAL
CO-INVESTMENT FUND, L.P.
By: /s/ STEVEN P. BIRD
--------------------------------
Steven P. Bird
General Partner
/s/ THOMAS J. DIETZ
-----------------------------------
Thomas J. Dietz
/s/ ROBERT A. DISHMAN
-----------------------------------
Robert A. Dishman
DYAX CHASE PARTNERS
(ALTA BIO), LLC
By Alta Chase BioPharma Management, LLC
By: /s/ DANIEL JANNEY
--------------------------------
Daniel Janney
Member
22
GENZYME CORPORATION
By: /s/ PETER WIRTH
--------------------------------
Peter Wirth
Executive Vice President and
Chief Legal Officer
H&Q HEALTHCARE INVESTORS
By: /s/ ALAN G. CARR
--------------------------------
Alan G. Carr
President
H&Q LIFE SCIENCES INVESTORS
By: /s/ ALAN G. CARR
--------------------------------
Alan G. Carr
President
ING BARING (U.S.) CAPITAL
COPRORATION
By: /s/ CHRISTOPHER S. MOORE
--------------------------------
Christopher S. Moore
Vice President
/s/ SUSAN DANA JONES
-----------------------------------
/s/ KENNETH ARNOLD
-----------------------------------
Susan Dana Jones and Kenneth Arnold as
Co-Owners
/s/ SYDNEY R. KNAFEL
-----------------------------------
Sydney R. Knafel
22
LOEB INVESTORS CO. 106C
By Pinpoint Partners Corporation
as General Partner
By: /s/ THOMAS L. KEMPNER
--------------------------------
Thomas L. Kempner, President
/s/ GEORGE J. MILSTEIN
-----------------------------------
/s/ ELIZABETH MILSTEIN
-----------------------------------
George J. Milstein and Elizabeth Milstein
as Co-Owners
/s/ JOSEPH E. MULLANEY, III
-----------------------------------
Joseph E. Mullaney, III
/s/ RICHARD H. OSGOOD
-----------------------------------
Richard H. Osgood
/s/ C. FRED TONEY
-----------------------------------
C. Fred Toney
/s/ CHARLES I. TYLER
-----------------------------------
/s/ MARGARET B. TYLER
-----------------------------------
Charles I. Tyler and Margaret B. Tyler
as Co-Owners
23
AMENDMENT TO THE
AMENDED AND RESTATED
REGISTRATION RIGHTS AGREEMENT
This Amendment (this "AMENDMENT") to the Amended and Restated
Registration Rights Agreement dated as of August 31, 1998 (as amended to date,
the "Registration Rights Agreement") is made as of October 24, 2000, among DYAX
CORP., a Delaware corporation (the "COMPANY"), and certain stockholders of the
Company that are signatories hereto (including for this purpose certain
stockholders who have agreed in writing to be bound by the terms of the
Registration Rights Agreement) (the "Stockholders").
RECITALS
A. The parties have entered into the Registration Rights Agreement,
which grants certain rights to the Stockholders relating to the registration of
their Registrable Shares (as that term is defined in the Registration Rights
Agreement).
B. The parties wish to amend the terms of the Registration Rights
Agreement.
NOW, THEREFORE, in consideration of the foregoing, the parties agree as
follows:
1. Section 3(a) of the Registration Rights Agreement is hereby amended
by replacing the words "within 20 days" from the third and fourth lines thereof
with the following words: "within 10 days."
2. Except as expressly modified hereby, the Registration Rights
Agreement shall remain in full force and effect in accordance with its original
terms, and this Amendment shall be governed, construed and enforced in
accordance with the terms thereof.
3. This Amendment may be executed in two or more counterparts, each of
which shall be deemed an original, and all of which together shall constitute
one and the same instrument.
[Remainder of Page Intentionally Left Blank]
IN WITNESS WHEREOF, the parties have executed this Amendment as of the
date first written above.
COMPANY:
DYAX CORP.
By: /s/ HENRY E. BLAIR
-----------------------------------------
Henry Blair
President
STOCKHOLDERS:
ALTA BIOPHARMA PARTNERS, L.P.
By Alta BioPharma Management, LLC
By: /s/ ALIX MARDUEL
--------------------------------------
Name: Alix Marduel
Title: Managing Director
ALTA EMBARCADERO BIOPHARMA, LLC
By: /s/ ELAINE WALKER
--------------------------------------
Name: Elaine Walker
Title: Under Power of Attorney
DYAX CHASE PARTNERS (ALTA BIO), LLC
By Alta Chase BioPharma Management, LLC
By: /s/ ALIX MARDUEL
-------------------------------------
Name: Alix Marduel
Title: Member
2
BANCBOSTON VENTURES
By: /s/ MARCIA T. BATES
-------------------------------------
Name: Marcia T. Bates
Title: Managing Director
GATEWAY VENTURE PARTNERS III, L.P.
By: Gateway Associates III, L.P., as
General Partner
By: /s/ GREGORY R. JOHNSON
-------------------------------------
Gregory R. Johnson, a General Partner
GATEWAY VENTURE PARTNERS II, L.P.
By: Gateway Associates II, L.P., as
General Partner
By: /s/ GREGORY R. JOHNSON
-------------------------------------
Gregory R. Johnson, a General Partner
GENZYME CORPORATION
By: /s/ PETER WIRTH
-------------------------------------
Name: Peter Wirth
Title: Executive Vice President
GMM I SBIC, INC.
By: GMM Investors Corp.,
as General Partner
By: /s/ JAMES GOODMAN
-------------------------------------
James Goodman
President
3
H&Q HEALTHCARE INVESTORS
By: /s/ KEVIN A. BISNER
-------------------------------------
Name: Kevin A. Bisner
Title: Secretary
H&Q LIFE SCIENCES INVESTORS
By: /s/ KEVIN A. BISNER
-------------------------------------
Name: Kevin A. Bisner
Title: Secretary
HEALTHCARE VENTURES V, L.P.
By: /s/ JEFFREY STEINBERG
-------------------------------------
Name: Jeffrey Steinberg
Title: Administrative Partner
LOEB INVESTORS CO. 106
By Pinpoint Partners Corporation,
As General Partner
By: /s/ THOMAS L. KEMPNER
-------------------------------------
Thomas L. Kempner
President
LOEB INVESTORS CO. 106A
By Pinpoint Partners Corporation,
As General Partner
By: /s/ THOMAS L. KEMPNER
-------------------------------------
Thomas L. Kempner
President
4
LOEB INVESTORS CO. 106B
By Pinpoint Partners Corporation,
As General Partner
By: /s/ THOMAS L. KEMPNER
-------------------------------------
Thomas L. Kempner
President
LOEB INVESTORS CO. 106C
By Pinpoint Partners Corporation,
As General Partner
By: /s/ THOMAS L. KEMPNER
-------------------------------------
Thomas L. Kempner
President
NEW YORK LIFE INSURANCE CO.
By: /s/ DENNIS J. PURCELL
-------------------------------------
Name: Dennis J. Purcell
Title: Managing Partner
OAK INVESTMENT PARTNERS IV,
LIMITED PARTNERSHIP
By Oak Associates IV, Limited Partnership,
as General Partner
By: /s/ EDWARD F. GLASSMEYER
-------------------------------------
Name: Edward F. Glassmeyer
Title: Managing Partner
5
OAK IV AFFILIATES FUND, LIMITED
PARTNERSHIP
By Oak IV Affiliates, as General Partner
By: /s/ EDWARD F. GLASSMEYER
-------------------------------------
Name: Edward F. Glassmeyer
Title: Managing Partner
PRINCE VENTURE PARTNERS IV
By Prince Ventures Limited Partnership,
As General Partner
By: /s/ JAMES W. FORDYCE
-------------------------------------
James W. Fordyce
General Partner
/s/ HENRY E. BLAIR
-------------------------------------
Henry E. Blair
L. EDWARD CANNON, CUSTODIAN
FOR ANDREW CRAWFORD LADNER,
UMUTMA
/s/ L.E. CANNON
-------------------------------------
L. Edward Cannon
L. EDWARD CANNON, CUSTODIAN
FOR SARAH JOHANNA LADNER,
UMUTMA
/s/ L.E. CANNON
-------------------------------------
L. Edward Cannon
/s/ ROBERT A. DISHMAN
-------------------------------------
Robert A. Dishman
/s/ HENRY R. LEWIS
-------------------------------------
Henry R. Lewis
6